A groundbreaking science facility which kickstarted the UK’s world leading Covid drug development and has advanced treatments of global health challenges from HIV to malaria and cancer will be upgraded and expanded through a more than £500 million investment, Science and Technology Secretary Michelle Donelan has announced today (Wednesday 6 September).
FDA approves EpiPen alternative, a nasal spray for anaphylaxis
On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and kids with severe allergic reactions. The approval introduces a competitor